Study of NBMI Treatment in Patients With Atypical Parkinsons (PSP or MSA)

Clinical trial NCT04184063 · COMPLETED

Trial details

NCT number: NCT04184063
Sponsor: EmeraMed
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Progressive Supranuclear Palsy Multiple System Atrophy

Start date: 2019-09-16
Primary completion: 2020-07-30
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.